FDA Approves Once-A-Day Lamictal XR as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
RESEARCH TRIANGLE PARK, N.C., Jan. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal XR (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy... (Source: Drugs.com - New Drug Approvals)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div

New Risks Found for Epilepsy Drugs
The FDA warned that 11 drugs used to treat epilepsy doubled the risk of suicidal thinking or behavior. The drugs include JJ's Topamax, GSK's Lamictal, Pfizer's Lyrica, and Novartis's Tegretol and Trileptal. (FDA statement) (Source: WSJ.com: Health)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div